GOVX GeoVax Labs Total Asset Value of Company
This chart of total asset price changes for GeoVax Labs, Inc. (GOVX), which currently has a value of 5.00, demonstrates the dynamics of GeoVax Labs, Inc. (GOVX). The company develops vaccines by leveraging partnerships with the defense sector and the NIH. However, the business faces intense pressure from global behemoths in the competition for grants. Meanwhile, the firm's development is largely independent of the economy, driven instead by the success of medical trials.
Analytical breakdowns and data insights for company GeoVax Labs Inc (GOVX)
- stock quotes and analyst forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio GeoVax Labs, Inc.|GOVX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio GeoVax Corp|GOVX - Company Aggregate Debts|Debts to Book Capitalization GeoVax Corp|GOVX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings GeoVax|Interim Coverage Ratio geovax.com
- net income and valuation multiples indicators:
Fundamental valuation:GeoVax Labs, Inc.
The stability of GeoVax Labs, Inc. (GOVX) is based on the creation of unique MVA vaccines for untapped market niches, which ensures significant pricing power during commercialization. The trend in the company's total assets, reverse-calculated via ROA, allows for the filtering of short-term market noise and an assessment of the real pace of resource base expansion, preventing the undervaluation of hidden imbalances between capital growth and actual profit.
Key competitors
Total Business Assets ARGX|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|Savara Corp - Company Total Assets|Company Balance Sheet Assets Rigel Corp (RIGL)|ANAB: Company Total Assets|Company Assets astriatx.com (ATXS)|Aggregate Company Assets enGene|Company Assets RAPT Therapeutics Inc. RAPT|Cumulative Company Assets JBIO (Aerovate Therapeutics Inc)|Aggregate Company Assets ACRS (Aclaris Therapeutics, Inc)|Company Total Assets KYTX (Kyverna Therapeutics)|Company Total Assets tizianalifesciences.com TLSA|CABA: Cumulative Company Assets|VTYX (Ventyx Biosciences Inc.) - Total Business Assets|THTX (Theratechnologies Inc) - Cumulative Company Assets|Avalo Therapeutics Inc - Aggregate Asset Value|Aggregate Company Assets Eledon Pharmaceuticals|Aggregate Company Assets AGEN|Company Total Assets CLYM|Company Total Assets Zura Bio Ltd (ZURA)|Company Total Assets ATYR (aTyr)|Adagene Inc - Aggregate Company Assets|IMA - Aggregate Company Assets|Company Total Asset Base Shattuck Labs, Inc. STTK|EQ (equilliumbio.com) - Cumulative Company Assets|Connect Biopharma Holdings Limited - Aggregate Asset Value|IMUX (Immunic Therapeutics) - Company Total Assets|Atara Biotherapeutics Inc (ATRA) - Company Total Asset Base|Aggregate Company Assets InflaRx N.V. (IFRX)|x4pharma.com - Total Business Assets|Company Total Assets ACET (Adicet Bio, Inc.)|CELU - Cumulative Company Assets|INMB: Cumulative Company Assets|Company Total Asset Base Barinthus Biotherapeutics Corp BRNS|KZR: Company Total Assets|Company Balance Sheet Assets sabbiotherapeutics.com SABS|Aggregate Company Assets Akari Therapeutics Plc|Company Assets Enlivex Therapeutics, Ltd. ENLV|Cumulative Company Assets QTTB (Q32 Bio Inc.)|Aggregate Company Assets EDSA (Edesa Biotech Corp)|iBio, Inc. - Cumulative Company Assets|CARM: Total Business Assets|XTLB - Aggregate Company Assets|Total Asset Value of Company BOLT|HCWB: Company Total Assets|Aptevo Therapeutics Inc. - Aggregate Asset Value|AIM (AIM ImmunoTech Inc.) - Company Total Assets|Company Total Assets Aditxt Corp|Aggregate Company Assets GRI Bio (GRI)|XRTX (XORTX Therapeutics Inc) - Aggregate Asset Value|Aggregate Company Assets ReShape Lifesciences HIND|REVB - Cumulative Company Assets|Indaptus Therapeutics - Company Total Assets|SCNI - Company Total Assets|CALI (calcimedica.com) - Cumulative Company Assets|Affimed N.V. - Aggregate Asset Value|ALLK (Allakos Inc) - Company Total Assets|HOOKIPA (HOOK) - Company Total Asset Base|Aggregate Company Assets IGM Biosciences, Inc. (IGMS)|Cumulative Company Assets iteostherapeutics.com ITOS|Aggregate Company Assets Ocean Biomedical OCEA|TCBP - Cumulative Company Assets|THRD: Cumulative Company Assets